Basking Biosciences, a clinical-stage biopharmaceutical company developing a first-in-class, targeted, reversible thrombolytic therapy for acute ischemic stroke (AIS), has announced the publication of preclinical research in Communications Biology, a Nature Portfolio journal. The study shows that its lead candidate, BB-031, restores blood flow in a microfluidic model of arterial occlusion… Read More
FUJIFILM Irvine Scientific has rebranded as FUJIFILM Biosciences, a decision the company hopes will build on FUJIFILM’s work in the life science industry. FUJIFILM Biosciences has pledged to continue its customer-focus, empowering scientists and researchers at every stage of discovery, development, and commercialisation. By offering a products and services… Read More
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Quin Wills, Co-founder… Read More
Metrion Biosciences, a specialist ion channel contract research and drug discovery company, and The KCNC1 Foundation, a not-for-profit organisation focused on the development of a treatment for an ultra-rare genetic disorder, have entered a collaboration to progress a hit identification research project for small molecule modulators of the potassium… Read More
Ochre Bio, a company developing therapies for liver health challenges, has closed $30 million in Series A financing, which will be used to translate the insights from their discovery research into RNA-based drug candidates, and then test these in human livers at their recently launched ‘Liver ICUs’ across the… Read More
Open Cell, a ‘hotel for scientists’ in London, UK, provides a cluster of small labs within a large shipping container facility, that are available for short-term rental by biotech startups with a range of shared services and facilities. As well as private labs, the facilities provide access to equipment worth… Read More
The latest DDW Sitting Down With sponsored podcast features Dominque Bröhl and Evert-Jan Uringa, Scientific Program Managers at Taconic Biosciences, who discuss how mouse model generation can be accelerated without any loss of quality. They offer insight into the latest developments, innovation and challenges in mouse model generation, how… Read More
Alamar Biosciences, a proteomics platform, and Abcam, innovators in life sciences research tools, have partnered to further their understanding of the human proteome. Proteomics The field of proteomic analysis is in the spotlight. Its advance not only enhances the understanding of fundamental biology, but also… Read More
Anticancer Bioscience, a company developing synthetic lethal approaches to precision oncology, have relocated to Tianfu International Biotown, in Chengdu, China, to accommodate its growth and expansion, and on the back of its recent financing. Biotown is considered the premier biotech research park in Chengdu, the capital of Sichuan province. The… Read More
Sixfold Bioscience (Sixfold), a company using computation and advanced chemistry to design RNA therapeutic delivery systems, has raised $10.5 million in its seed funding round, which will support the continued development of the company’s Mergo RNA therapeutics delivery platform. Investors Investors in the seed round included Cantos… Read More
Neurocrine Biosciences and Sosei Group Corporation have collaborated to develop novel muscarinic receptor agonists, which Neurocrine Biosciences intends to study in the treatment for schizophrenia, dementia and other neuropsychiatric disorders. The agreement terms Under the terms of the agreement, Neurocrine Biosciences gains development and commercialisation rights to… Read More
Twist Bioscience has acquired Abveris, which will offer Twist comprehensive antibody discovery and characterisation services using its DiversimAb family of hyperimmune mouse models, the output of which can be humanised using the Twist antibody optimisation solution to develop biologics for rapid clinical advancement. Emily Leproust, CEO and co-founder of Twist Bioscience, believes that the addition of the Abveris discovery… Read More
Michael-John O’Connor, Director of Biochemical Services at BioPharmaSpec, discusses analysing biosimilars, glycosylated mAbs and PEGylated proteins with Lu Rahman. LR: Outline the importance of bio-molecules in drug discovery. What is their potential within therapeutic development? MJOC: The FDA’s recent approval of Biocon’s Semglee (long acting Insulin glargine) is the first example of… Read More
RareCan has received approval from the NHS Research Ethics Committee to establish its BioResource at Newcastle University, which will store tissue samples from rare cancer patients collected during surgery, will be accessible to scientists around the globe undertaking research into the prevention, diagnosis or treatment of rare cancers. This reduces… Read More
Culture Biosciences has selected Scispot.io to digitise and automate its media preparation workflows while maintaining an audit trail. Connecting data from multiple sources with Scispot, Culture Bioscience aims to reduce its experiment failure rate and improve the scientific output. “Scispot is designed for mapping custom biomanufacturing workflows developed by Culture Biosciences. Using Scispot, Culture… Read More
Crown Bioscience has launched its ‘3D Ex Vivo Patient Tissue Platform’ which, using freshly collected patient tumour material, can accurately measure oncology and immuno-oncology drug-induced tumour killing and endogenous immune cell proliferation in a high throughput format. Researchers presented data on the new platform at 2021’s AACR-NCI-EORTC International Conference on Molecular Targets and… Read More
